SC
NTUS

Skylands Capital’s Natus Medical Inc NTUS Stock Holding History

Skylands Capital’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-53,094
Closed -$1.79M – 176
2018
Q1 		$1.79M Buy
+53,094
New +$1.68M 0.24% 84
2013
Q3 		– Sell
-48,700
Closed -$665K – 235
2013
Q2 		$665K Buy
+48,700
New +$664K 0.08% 162

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Skylands Capital's NTUS Position: Q2 2018 in Review

Skylands Capital sold out of Natus Medical Inc (NTUS) in Q2 2018, closing a stake of 53,094 shares — an estimated $1.79M sold.

Skylands Capital first reported a position in NTUS in Q2 2013 and held it in 2 quarters. The position peaked at $1.79M in Q1 2018. 175 funds tracked by Wall St. Rank hold NTUS as of Q2 2018.

  • Skylands Capital reported no remaining Natus Medical Inc position as of Q2 2018 after selling out during the quarter.
  • Skylands Capital sold 53,094 Natus Medical Inc shares in Q2 2018, an estimated $1.79M.
  • Skylands Capital first reported a position in Natus Medical Inc in Q2 2013 and held it in 2 quarters.
  • Skylands Capital's Natus Medical Inc position peaked at $1.79M in Q1 2018.
  • 175 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2018.

Based on Skylands Capital's 13F filing for Q2 2018, filed 24 Jul 2018.